Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Breast Neoplasms and CTSO[original query] |
---|
Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention. Cancer discovery 2013 Jul 3 (7): 812-25. Ingle James N, Liu Mohan, Wickerham D Lawrence, Schaid Daniel J, Wang Liewei, Mushiroda Taisei, Kubo Michiaki, Costantino Joseph P, Vogel Victor G, Paik Soonmyung, Goetz Matthew P, Ames Matthew M, Jenkins Gregory D, Batzler Anthony, Carlson Erin E, Flockhart David A, Wolmark Norman, Nakamura Yusuke, Weinshilboum Richard |
Prognostic impact of a single-nucleotide polymorphism near the CTSO gene in hormone receptor-positive breast cancer patients. International journal of clinical oncology 2015 Oct . Hato Yukari, Kondo Naoto, Yoshimoto Nobuyasu, Endo Yumi, Asano Tomoko, Dong Yu, Nishimoto Mayumi, Takahashi Satoru, Fujii Yoshitaka, Nakanishi Ryoichi, Toyama Tatsu |
Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trials. Breast cancer research and treatment 2016 Jul . Brentnall Adam R, Cuzick Jack, Byers Helen, Segal Corrinne, Reuter Caroline, Detre Simone, Sestak Ivana, Howell Anthony, Powles Trevor J, Newman William G, Dowsett Mitche |
SNPs near the cysteine proteinase cathepsin O gene (CTSO) determine tamoxifen sensitivity in ER?-positive breast cancer through regulation of BRCA1. PLoS genetics 2017 10 13 (10): e1007031. Cairns Junmei, Ingle James N, Wickerham Lawrence D, Weinshilboum Richard, Liu Mohan, Wang Liew |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: